Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,098 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-line Platinum-based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05).
Park I, Yoon S, Kim I, Park K, Lee S, Keam B, Park JH, Kim JY, Choi YJ, Sohn BS, Lee JL. Park I, et al. Among authors: park jh, park k. Cancer Res Treat. 2024 Dec 27. doi: 10.4143/crt.2024.1003. Online ahead of print. Cancer Res Treat. 2024. PMID: 39727010 Free article.
Four versus six cycles of platinum-based chemotherapy for advanced Urothelial carcinoma in the era of immune checkpoint inhibitors: A retrospective cohort study (FOCUS, KCSG-GU23-08).
Park K, Kim EJ, Kim JY, Kim H, Park I, Park JH, Sohn BS, Lee HJ, Jo J, Huh SJ, Lee JL. Park K, et al. Among authors: park jh, park i. Curr Probl Cancer. 2024 Dec;53:101149. doi: 10.1016/j.currproblcancer.2024.101149. Epub 2024 Sep 22. Curr Probl Cancer. 2024. PMID: 39312854
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03.
Bae WK, Lee HJ, Park SH, Kim JH, Kim HJ, Maeng CH, Park I, Sohn BS, Kim JA, Lee KH, Lim DH, Chang H, Kim SM, Kim HY, Song H, Lim S, Byun JH, Jung HA. Bae WK, et al. Among authors: park i, park sh. Cancer Med. 2019 Sep;8(12):5431-5437. doi: 10.1002/cam4.2446. Epub 2019 Jul 29. Cancer Med. 2019. PMID: 31353788 Free PMC article.
Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16).
Park I, Kim BS, Lim HY, Kim HJ, Lee HJ, Choi YJ, Park KH, Lee KH, Yoon S, Hong B, Hong JH, Ahn H, Lee JL. Park I, et al. Among authors: park kh. Eur J Cancer. 2020 Mar;127:183-190. doi: 10.1016/j.ejca.2019.08.034. Epub 2019 Oct 24. Eur J Cancer. 2020. PMID: 31668839 Clinical Trial.
6,098 results